Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Sep 01, 2009 | Chief Financial Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 220 | $9.83 | 32,295 | |
| Oct 01, 2009 | Chief Financial Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 220 | $8.75 | 32,075 | |
| Nov 04, 2009 | Director | Open market or private purchase of non-derivative or derivative security | Form 4 | 20,000 | $4.13 | 20,000 | |
| Nov 06, 2009 | Corporate Controller | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Nov 06, 2009 | Corporate Controller | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Nov 06, 2009 | Corporate Controller | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Nov 06, 2009 | Corporate Controller | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Nov 06, 2009 | Corporate Controller | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Nov 06, 2009 | Corporate Controller | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Nov 16, 2009 | Chief Medical Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 80,000 | -- | 80,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.